Scotland · NHS Scotland MSAN
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials - Update
MSAN(2024)7 · Level 2 · issued 08 Mar 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 2. Salbutamol 2.5mg/2.5ml nebules will be in limited supply from mid-April until late June 2024. | Limited supply | late June 2024 |
| 3. Salbutamol 5mg/2.5ml nebules will remain available, however, cannot support an increase in | Available — cannot support uplift | — |
| 5. Alternative beta2-agonists for nebulisation and intravenous administration remain available, | Available | — |
| however, they cannot support an increase in demand. | Available — cannot support uplift | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2024:7
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
ebec98ac936d56329485c277533c7d02f3bb980018ba619c5209a4d511ddf1b6sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2024-07.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.